- Home
- UMC vs BNTX Comparison
UMC vs BNTX Comparison
Compare UMC & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UMC | BNTX |
|---|---|---|
| Founded | 1980 | 2008 |
| Country | Taiwan | Germany |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.3B | 24.2B |
| IPO Year | 1997 | 2019 |
Fundamental Metrics
Financial Performance| Metric | UMC | BNTX |
|---|---|---|
| Price | $18.23 | $92.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $133.46 |
| AVG Volume (30 Days) | ★ 13.7M | 727.4K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.92% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.22 | N/A |
| Revenue Next Year | $10.15 | $3.37 |
| P/E Ratio | $18.95 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.56 | $79.81 |
| 52 Week High | $18.45 | $124.00 |
Technical Indicators
Market Signals| Indicator | UMC | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 81.76 | 45.35 |
| Support Level | $7.03 | $90.67 |
| Resistance Level | N/A | $112.44 |
| Average True Range (ATR) | 0.69 | 2.97 |
| MACD | 0.16 | -0.41 |
| Stochastic Oscillator | 94.93 | 44.47 |
Price Performance
Historical ComparisonAbout UMC United Microelectronics Corporation (NEW)
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 5% market share in 2024 after TSMC and SMIC. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the US, and South Korea. UMC features a diverse customer base that includes Texas Instruments, MediaTek, Intel, Broadcom, Novatek, and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 19,000 people as of February 2025.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.